LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
28.69
-0.58 (-1.98%)
Jun 10, 2026, 2:45 PM EDT - Market open
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $822.73 million as of June 10, 2026.
Market Cap
822.73M
Enterprise Value
474.19M
1-Year Change
n/a
Ranking
Category
Stock Price
$28.69
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $822.73M, an increase of 172.88%. That is a compound annual growth rate of 286.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 839.37M | 49.05% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 850.04M |
| Lexicon Pharmaceuticals | 848.42M |
| Alpha Tau Medical | 843.15M |
| Theravance Biopharma | 839.80M |
| Arbutus Biopharma | 839.54M |
| Inventiva | 839.46M |
| MeiraGTx Holdings | 833.49M |
| Cullinan Therapeutics | 830.30M |